LUPIN Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > lupin

Technical Analysis

Technical Strength: 3.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 47.4. According to RSI analysis, lupin is marginally weak. 4.0 LUPIN RSI Chart
MACD (?) MACD: 0.827 and Signal Line: -1.92. According to MACD analysis, lupin is technically strong. 8.0 LUPIN MACD Chart
Simple Moving Average (?) Price just got below it's 50-day simple moving average which is a negative signal. Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, lupin is in a strong downtrend. Major resistance levels are 1463.078, 1471.344, 1513.631. 0.0 LUPIN Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 50-day exponential moving average which is a negative signal. Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, lupin is in a strong downtrend. Major resistance levels are 1464.623, 1469.253, 1517.908. 0.0 LUPIN Exponential Moving Average Chart
Bollinger Bands (?) Bollinger bandwidth suggests a squeeze is happening, watch for a breakout.%b is 0.355. According to bollinger bands, lupin has moved strongly towards lower band, which is a negative signal. 1.0 LUPIN Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 1481.5798 and 1499.15. Support level is 1424.7. 2.5 LUPIN Fibonacci Retracement Chart
Average True Range (?) ATR: 23.9 NA LUPIN Average True Range Chart
Average Directional Index (?) ADX is 10.2 which means LUPIN is in a trading range and there is no trend. NA LUPIN Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 27, 2017
Open Price 1486.9
High Price 1486.9
Low Price 1455.0
Close Price 1457.75
Absolute Change -30.05
Percentage Change -2.02%
Weekly Change -0.474%
Monthly Change 0.534%
Yearly Change -12.9%
52-week high 1750.0
52-week low 1280.0
Corporate Actions
ExDate Purpose
July 25, 2016 AGM/DIV-RS 7.50 PER SHARE
July 21, 2014 AGM/DIV-RS 3/- PER SHARE
February 13, 2014 INT DIV-RS 3/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.483
Confidence in Beta0.0862%
Market Capital Rs. 65625.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 63.72
TTM Price-to-Earnings (P/E) Ratio 22.9
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 March 2017: Deliverable Quantity:5.1e+05 NA LUPIN Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 March 2017: Daily Volatility:0.1872 NA LUPIN Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 March 2017: PCR_OI:0.432 PCR:0.406 NA LUPIN PCR Chart
Premium (?) 27 March 2017 Premium: 3.25 Futures OI:6514800.0 NA LUPIN Premium Chart
Option_MAX_OI (?) 27 March 2017: Price:1457.75 Put with maximum OI:1450.0 Call with maximum OI:1500.0 NA LUPIN Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 30, 2017 1461.0 6514800.0 4919.0 7675.0 1457.75
April 27, 2017 1465.55 2004400.0 3213.0 5718.0 1457.75
May 25, 2017 1472.0 4400.0 7.0 7.0 1457.75

Announcements

March 24, 2017 LupinESOPs/ESOS/ESPSn Limited has informed the Exchange that the Allotment Committee of Directors at its meeting held on March 24, 2017 has allotted 46911 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company.
March 23, 2017 LupinPress Releasen Limited has informed the Exchange regarding a press release dated March 23, 2017, titled "Lupin Receives FDA Approval for Generic TOBI Inhalation Solution".
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 23, 2017 February 09, 2017 InterResultsr alia to consider and take on record the unaudited financial results for the quarter ended December 31, 2016
October 17, 2016 November 09, 2016 interResultsr alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2016.
See all Board Meetings

LUPIN is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1414 Rs. 1435 Rs. 1446 Rs. 1467 Rs. 1478 Rs. 1498 Rs. 1510